Component: (Network and Table)
Network
00500 - Statement - CONSOLIDATED STATEMENTS OF CASH FLOWS
(http://www.cantelmedical.com/role/StatementConsolidatedStatementsOfCashFlows)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Reporting Entity [Axis]0000019446 (http://www.sec.gov/CIK)
CONSOLIDATED STATEMENTS OF CASH FLOWSPeriod [Axis]
2015-08-01 - 2016-07-31
2014-08-01 - 2015-07-31
2013-08-01 - 2014-07-31
CONSOLIDATED STATEMENTS OF CASH FLOWS
 
 
 
Cash flows from operating activities
 
 
 
Net income
59,953,000  
47,953,000  
43,265,000  
Adjustments to reconcile net income to net cash provided by operating activities:
 
 
 
Depreciation
11,989,000  
10,692,000  
8,245,000  
Amortization
13,095,000  
13,265,000  
10,641,000  
Stock-based compensation expense
8,361,000  
5,867,000  
5,409,000  
Amortization of debt issuance costs
401,000  
401,000  
440,000  
Loss on disposal of fixed assets
553,000  
360,000  
501,000  
Loss on sale of business
 
2,206,000  
 
Impairment of assets
 
1,287,000  
 
Fair value adjustments to acquisition related liabilities
(687,000) 
(2,585,000) 
219,000  
Deferred income taxes
(1,710,000) 
(1,449,000) 
(1,218,000) 
Excess tax benefits from stock-based compensation
(1,179,000) 
(3,168,000) 
(4,391,000) 
Changes in assets and liabilities, net of effects of business acquisitions/divestiture:
 
 
 
Accounts receivable
(12,729,000) 
(3,905,000) 
(6,149,000) 
Inventories
(15,558,000) 
(10,075,000) 
(2,658,000) 
Prepaid expenses and other current assets
(2,850,000) 
(2,996,000) 
(2,388,000) 
Accounts payable and other current liabilities
17,657,000  
(3,347,000) 
6,205,000  
Income taxes
2,972,000  
4,564,000  
6,151,000  
Net cash provided by operating activities
80,268,000  
 
59,070,000  
 
64,272,000  
 
Cash flows from investing activities
 
 
 
Capital expenditures
(18,889,000) 
(12,760,000) 
(13,541,000) 
Proceeds from disposal of fixed assets
96,000  
25,000  
14,000  
Proceeds from sale of business, net of cash retained and disposal costs
 
3,767,000  
 
Acquisition of businesses, net of cash acquired
(94,528,000) 
(43,567,000) 
(33,547,000) 
Other, net
339,000  
241,000  
(358,000) 
Net cash used in investing activities
(112,982,000) 
 
(52,294,000) 
 
(47,432,000) 
 
Cash flows from financing activities
 
 
 
Borrowings under revolving credit facility
96,500,000  
47,000,000  
28,000,000  
Repayments under term loan facility
  
(5,000,000) 
Repayments under revolving credit facility
(59,000,000) 
(49,000,000) 
(37,500,000) 
Debt modification costs
  
(1,314,000) 
Proceeds from exercises of stock options
 
608,000  
634,000  
Dividends paid
(5,005,000) 
(4,154,000) 
(3,721,000) 
Excess tax benefits from stock-based compensation
1,179,000  
3,168,000  
4,391,000  
Purchases of treasury stock
(3,732,000) 
(3,727,000) 
(4,439,000) 
Net cash provided by (used in) financing activities
29,942,000  
 
(6,105,000) 
 
(18,949,000) 
 
Effect of exchange rate changes on cash and cash equivalents
(581,000) 
(732,000) 
(186,000) 
Decrease in cash and cash equivalents
(3,353,000) 
 
(61,000) 
 
(2,295,000) 
 
Cash and cash equivalents at beginning of period
31,720,000  
31,781,000  
34,076,000  
Cash and cash equivalents at end of period
28,367,000  
 
31,720,000  
 
31,781,000